S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.38%) $966.30
USD/EUR
(-0.36%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

リアルタイムの更新: Smith & Nephew SNATS Inc. [SNN]

取引所: NYSE セクター: Healthcare 産業: Medical - Devices
最終更新日時4 5月 2024 @ 05:00

1.39% $ 24.78

Live Chart Being Loaded With Signals

Commentary (4 5月 2024 @ 05:00):
Profile picture for Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures...

Stats
本日の出来高 1.06M
平均出来高 959 743
時価総額 10.80B
EPS $0 ( 2024-02-27 )
次の収益日 ( $0 ) 2024-08-01
Last Dividend $0.288 ( 2023-10-05 )
Next Dividend $0 ( N/A )
P/E 41.30
ATR14 $0.0100 (0.04%)

ボリューム 相関

長: -0.17 (neutral)
短: 0.78 (moderate)
Signal:(56.487) Neutral

Smith & Nephew SNATS Inc. 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Smith & Nephew SNATS Inc. 相関 - 通貨/商品

The country flag 0.46
( neutral )
The country flag 0.84
( strong )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.51
( weak negative )
The country flag 0.59
( weak )

Smith & Nephew SNATS Inc. 財務諸表

Annual 2023
収益: $5.55B
総利益: $3.70B (66.70 %)
EPS: $0.600
FY 2023
収益: $5.55B
総利益: $3.70B (66.70 %)
EPS: $0.600
FY 2022
収益: $5.22B
総利益: $3.70B (70.85 %)
EPS: $0.510
FY 2021
収益: $5.21B
総利益: $3.67B (70.40 %)
EPS: $1.196

Financial Reports:

No articles found.

Smith & Nephew SNATS Inc. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.288
(N/A)
$0
(N/A)
$0.462
(N/A)
$0
(N/A)
$0
(N/A)
$0.288
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Smith & Nephew SNATS Inc. Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.49 - Stable (10.24%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.139 2000-05-04
Last Dividend $0.288 2023-10-05
Next Dividend $0 N/A
Payout Date 2023-11-01
Next Payout Date N/A
# dividends 48 --
Total Paid Out $10.43 --
Avg. Dividend % Per Year 1.50% --
Score 4.34 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 4.49
Div. Directional Score 7.54 --
Next Divdend (Est)
(2024-09-30)
$0.288 Estimate 7.53 %
Dividend Stability
0.30 Poor
Dividend Score
4.34
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
2000 $0.194 2.88%
2001 $0.146 1.58%
2002 $0.154 1.28%
2003 $0.169 1.36%
2004 $0.184 1.10%
2005 $0.194 0.96%
2006 $0.204 1.08%
2007 $0.223 1.07%
2008 $0.247 1.07%
2009 $0.271 2.08%
2010 $0.299 1.45%
2011 $0.328 1.56%
2012 $0.414 2.12%
2013 $0.532 2.39%
2014 $0.560 1.98%
2015 $0.608 1.69%
2016 $0.626 1.80%
2017 $0.616 2.05%
2018 $0.734 2.10%
2019 $0.728 2.00%
2020 $0.750 1.55%
2021 $0.750 1.75%
2022 $0.750 2.14%
2023 $0.750 2.75%
2024 $0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
PHK Dividend Royal 2023-11-10 Monthly 22 6.88% 8.50
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50
ZTR Dividend King 2024-02-09 Monthly 37 8.35% 8.50
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
KIO Dividend Royal 2023-12-14 Monthly 12 7.05% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.04751.5009.0510.00[0 - 0.5]
returnOnAssetsTTM0.02631.2009.1210.00[0 - 0.3]
returnOnEquityTTM0.05021.500-0.553-0.830[0.1 - 1]
payoutRatioTTM1.247-1.00010.00-10.00[0 - 1]
currentRatioTTM1.7750.8006.134.90[1 - 3]
quickRatioTTM0.6790.800-0.709-0.567[0.8 - 2.5]
cashRatioTTM0.1331.500-0.372-0.558[0.2 - 2]
debtRatioTTM0.294-1.5005.09-7.64[0 - 0.6]
interestCoverageTTM5.491.0009.089.08[3 - 30]
operatingCashFlowPerShareTTM1.3842.009.5410.00[0 - 30]
freeCashFlowPerShareTTM0.4122.009.7910.00[0 - 20]
debtEquityRatioTTM0.564-1.5007.75-10.00[0 - 2.5]
grossProfitMarginTTM0.6881.0001.8621.862[0.2 - 0.8]
operatingProfitMarginTTM0.1371.0009.259.25[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2051.0009.979.97[0.2 - 2]
assetTurnoverTTM0.5530.8009.647.72[0.5 - 2]
Total Score10.60

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM40.621.0006.000[1 - 100]
returnOnEquityTTM0.05022.50-0.356-0.830[0.1 - 1.5]
freeCashFlowPerShareTTM0.4122.009.8610.00[0 - 30]
dividendYielPercentageTTM3.071.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.3842.009.5410.00[0 - 30]
payoutRatioTTM1.2471.50010.00-10.00[0 - 1]
pegRatioTTM-1.5901.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1091.0009.770[0.1 - 0.5]
Total Score4.49

Smith & Nephew SNATS Inc.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。